nodes	percent_of_prediction	percent_of_DWPC	metapath
Penciclovir—Application site reaction—Salbutamol—chronic obstructive pulmonary disease	0.0263	0.0263	CcSEcCtD
Penciclovir—Leukocytoclastic vasculitis—Montelukast—chronic obstructive pulmonary disease	0.0261	0.0261	CcSEcCtD
Penciclovir—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.0203	0.0203	CcSEcCtD
Penciclovir—Skin discolouration—Formoterol—chronic obstructive pulmonary disease	0.0145	0.0145	CcSEcCtD
Penciclovir—Skin discolouration—Arformoterol—chronic obstructive pulmonary disease	0.0145	0.0145	CcSEcCtD
Penciclovir—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.0139	0.0139	CcSEcCtD
Penciclovir—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.0136	0.0136	CcSEcCtD
Penciclovir—Dysmenorrhoea—Salbutamol—chronic obstructive pulmonary disease	0.0136	0.0136	CcSEcCtD
Penciclovir—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.012	0.012	CcSEcCtD
Penciclovir—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.0113	0.0113	CcSEcCtD
Penciclovir—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.011	0.011	CcSEcCtD
Penciclovir—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.0104	0.0104	CcSEcCtD
Penciclovir—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.0103	0.0103	CcSEcCtD
Penciclovir—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00995	0.00995	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00952	0.00952	CcSEcCtD
Penciclovir—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00901	0.00901	CcSEcCtD
Penciclovir—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00893	0.00893	CcSEcCtD
Penciclovir—Migraine—Salbutamol—chronic obstructive pulmonary disease	0.00882	0.00882	CcSEcCtD
Penciclovir—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00837	0.00837	CcSEcCtD
Penciclovir—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00792	0.00792	CcSEcCtD
Penciclovir—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00757	0.00757	CcSEcCtD
Penciclovir—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00752	0.00752	CcSEcCtD
Penciclovir—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.0073	0.0073	CcSEcCtD
Penciclovir—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00727	0.00727	CcSEcCtD
Penciclovir—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00713	0.00713	CcSEcCtD
Penciclovir—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.0071	0.0071	CcSEcCtD
Penciclovir—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00678	0.00678	CcSEcCtD
Penciclovir—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00677	0.00677	CcSEcCtD
Penciclovir—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00664	0.00664	CcSEcCtD
Penciclovir—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00659	0.00659	CcSEcCtD
Penciclovir—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00647	0.00647	CcSEcCtD
Penciclovir—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.0064	0.0064	CcSEcCtD
Penciclovir—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.0064	0.0064	CcSEcCtD
Penciclovir—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00629	0.00629	CcSEcCtD
Penciclovir—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00626	0.00626	CcSEcCtD
Penciclovir—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00617	0.00617	CcSEcCtD
Penciclovir—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00609	0.00609	CcSEcCtD
Penciclovir—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00609	0.00609	CcSEcCtD
Penciclovir—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00608	0.00608	CcSEcCtD
Penciclovir—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00608	0.00608	CcSEcCtD
Penciclovir—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00601	0.00601	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00599	0.00599	CcSEcCtD
Penciclovir—Delirium—Prednisone—chronic obstructive pulmonary disease	0.00598	0.00598	CcSEcCtD
Penciclovir—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00597	0.00597	CcSEcCtD
Penciclovir—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00584	0.00584	CcSEcCtD
Penciclovir—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0058	0.0058	CcSEcCtD
Penciclovir—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00579	0.00579	CcSEcCtD
Penciclovir—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00576	0.00576	CcSEcCtD
Penciclovir—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00575	0.00575	CcSEcCtD
Penciclovir—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00575	0.00575	CcSEcCtD
Penciclovir—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00575	0.00575	CcSEcCtD
Penciclovir—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00567	0.00567	CcSEcCtD
Penciclovir—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00563	0.00563	CcSEcCtD
Penciclovir—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00561	0.00561	CcSEcCtD
Penciclovir—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.0056	0.0056	CcSEcCtD
Penciclovir—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.0056	0.0056	CcSEcCtD
Penciclovir—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00546	0.00546	CcSEcCtD
Penciclovir—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00543	0.00543	CcSEcCtD
Penciclovir—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00532	0.00532	CcSEcCtD
Penciclovir—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00529	0.00529	CcSEcCtD
Penciclovir—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00522	0.00522	CcSEcCtD
Penciclovir—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00522	0.00522	CcSEcCtD
Penciclovir—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00519	0.00519	CcSEcCtD
Penciclovir—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00512	0.00512	CcSEcCtD
Penciclovir—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00505	0.00505	CcSEcCtD
Penciclovir—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00505	0.00505	CcSEcCtD
Penciclovir—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00501	0.00501	CcSEcCtD
Penciclovir—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00495	0.00495	CcSEcCtD
Penciclovir—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00493	0.00493	CcSEcCtD
Penciclovir—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00487	0.00487	CcSEcCtD
Penciclovir—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00485	0.00485	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00483	0.00483	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00483	0.00483	CcSEcCtD
Penciclovir—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00477	0.00477	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00473	0.00473	CcSEcCtD
Penciclovir—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00473	0.00473	CcSEcCtD
Penciclovir—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00459	0.00459	CcSEcCtD
Penciclovir—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00458	0.00458	CcSEcCtD
Penciclovir—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00458	0.00458	CcSEcCtD
Penciclovir—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00457	0.00457	CcSEcCtD
Penciclovir—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00453	0.00453	CcSEcCtD
Penciclovir—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00453	0.00453	CcSEcCtD
Penciclovir—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00452	0.00452	CcSEcCtD
Penciclovir—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00448	0.00448	CcSEcCtD
Penciclovir—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00447	0.00447	CcSEcCtD
Penciclovir—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00444	0.00444	CcSEcCtD
Penciclovir—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00434	0.00434	CcSEcCtD
Penciclovir—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00432	0.00432	CcSEcCtD
Penciclovir—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00428	0.00428	CcSEcCtD
Penciclovir—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00426	0.00426	CcSEcCtD
Penciclovir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00419	0.00419	CcSEcCtD
Penciclovir—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00415	0.00415	CcSEcCtD
Penciclovir—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00415	0.00415	CcSEcCtD
Penciclovir—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.0041	0.0041	CcSEcCtD
Penciclovir—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00409	0.00409	CcSEcCtD
Penciclovir—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00406	0.00406	CcSEcCtD
Penciclovir—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00405	0.00405	CcSEcCtD
Penciclovir—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00402	0.00402	CcSEcCtD
Penciclovir—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00402	0.00402	CcSEcCtD
Penciclovir—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00399	0.00399	CcSEcCtD
Penciclovir—Pain—Formoterol—chronic obstructive pulmonary disease	0.00399	0.00399	CcSEcCtD
Penciclovir—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00396	0.00396	CcSEcCtD
Penciclovir—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00394	0.00394	CcSEcCtD
Penciclovir—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00392	0.00392	CcSEcCtD
Penciclovir—Pain—Montelukast—chronic obstructive pulmonary disease	0.00391	0.00391	CcSEcCtD
Penciclovir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.0039	0.0039	CcSEcCtD
Penciclovir—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00386	0.00386	CcSEcCtD
Penciclovir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00386	0.00386	CcSEcCtD
Penciclovir—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00384	0.00384	CcSEcCtD
Penciclovir—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00384	0.00384	CcSEcCtD
Penciclovir—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00384	0.00384	CcSEcCtD
Penciclovir—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00382	0.00382	CcSEcCtD
Penciclovir—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00381	0.00381	CcSEcCtD
Penciclovir—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00381	0.00381	CcSEcCtD
Penciclovir—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.0038	0.0038	CcSEcCtD
Penciclovir—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00377	0.00377	CcSEcCtD
Penciclovir—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00374	0.00374	CcSEcCtD
Penciclovir—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00371	0.00371	CcSEcCtD
Penciclovir—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00371	0.00371	CcSEcCtD
Penciclovir—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00369	0.00369	CcSEcCtD
Penciclovir—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00369	0.00369	CcSEcCtD
Penciclovir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00368	0.00368	CcSEcCtD
Penciclovir—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00364	0.00364	CcSEcCtD
Penciclovir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00364	0.00364	CcSEcCtD
Penciclovir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00364	0.00364	CcSEcCtD
Penciclovir—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00363	0.00363	CcSEcCtD
Penciclovir—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00363	0.00363	CcSEcCtD
Penciclovir—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00362	0.00362	CcSEcCtD
Penciclovir—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Penciclovir—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.0036	0.0036	CcSEcCtD
Penciclovir—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.0035	0.0035	CcSEcCtD
Penciclovir—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00348	0.00348	CcSEcCtD
Penciclovir—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00344	0.00344	CcSEcCtD
Penciclovir—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00344	0.00344	CcSEcCtD
Penciclovir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00343	0.00343	CcSEcCtD
Penciclovir—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00337	0.00337	CcSEcCtD
Penciclovir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00335	0.00335	CcSEcCtD
Penciclovir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00335	0.00335	CcSEcCtD
Penciclovir—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.0033	0.0033	CcSEcCtD
Penciclovir—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.0033	0.0033	CcSEcCtD
Penciclovir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00328	0.00328	CcSEcCtD
Penciclovir—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00325	0.00325	CcSEcCtD
Penciclovir—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00323	0.00323	CcSEcCtD
Penciclovir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00319	0.00319	CcSEcCtD
Penciclovir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00319	0.00319	CcSEcCtD
Penciclovir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00316	0.00316	CcSEcCtD
Penciclovir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00313	0.00313	CcSEcCtD
Penciclovir—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00312	0.00312	CcSEcCtD
Penciclovir—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.0031	0.0031	CcSEcCtD
Penciclovir—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00308	0.00308	CcSEcCtD
Penciclovir—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00308	0.00308	CcSEcCtD
Penciclovir—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00302	0.00302	CcSEcCtD
Penciclovir—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00302	0.00302	CcSEcCtD
Penciclovir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00301	0.00301	CcSEcCtD
Penciclovir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00297	0.00297	CcSEcCtD
Penciclovir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00297	0.00297	CcSEcCtD
Penciclovir—Rash—Formoterol—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Penciclovir—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Penciclovir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Penciclovir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Penciclovir—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Penciclovir—Headache—Formoterol—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Penciclovir—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00291	0.00291	CcSEcCtD
Penciclovir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00291	0.00291	CcSEcCtD
Penciclovir—Rash—Montelukast—chronic obstructive pulmonary disease	0.00288	0.00288	CcSEcCtD
Penciclovir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00288	0.00288	CcSEcCtD
Penciclovir—Headache—Montelukast—chronic obstructive pulmonary disease	0.00286	0.00286	CcSEcCtD
Penciclovir—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00283	0.00283	CcSEcCtD
Penciclovir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.0028	0.0028	CcSEcCtD
Penciclovir—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00278	0.00278	CcSEcCtD
Penciclovir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.00277	CcSEcCtD
Penciclovir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00277	0.00277	CcSEcCtD
Penciclovir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00277	0.00277	CcSEcCtD
Penciclovir—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00276	0.00276	CcSEcCtD
Penciclovir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00271	0.00271	CcSEcCtD
Penciclovir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00262	0.00262	CcSEcCtD
Penciclovir—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00257	0.00257	CcSEcCtD
Penciclovir—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Penciclovir—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00226	0.00226	CcSEcCtD
Penciclovir—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00225	0.00225	CcSEcCtD
Penciclovir—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00216	0.00216	CcSEcCtD
Penciclovir—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00208	0.00208	CcSEcCtD
Penciclovir—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00208	0.00208	CcSEcCtD
Penciclovir—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00206	0.00206	CcSEcCtD
Penciclovir—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00201	0.00201	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.0019	0.0019	CcSEcCtD
Penciclovir—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00186	0.00186	CcSEcCtD
Penciclovir—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.0018	0.0018	CcSEcCtD
Penciclovir—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00178	0.00178	CcSEcCtD
Penciclovir—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Penciclovir—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00165	0.00165	CcSEcCtD
Penciclovir—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00159	0.00159	CcSEcCtD
Penciclovir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00159	0.00159	CcSEcCtD
Penciclovir—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00158	0.00158	CcSEcCtD
Penciclovir—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00158	0.00158	CcSEcCtD
Penciclovir—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00151	0.00151	CcSEcCtD
Penciclovir—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.0015	0.0015	CcSEcCtD
Penciclovir—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.0015	0.0015	CcSEcCtD
Penciclovir—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Penciclovir—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00145	0.00145	CcSEcCtD
Penciclovir—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Penciclovir—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Penciclovir—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.0013	0.0013	CcSEcCtD
Penciclovir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Penciclovir—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Penciclovir—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00117	CcSEcCtD
Penciclovir—Rash—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Penciclovir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Penciclovir—Headache—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Penciclovir—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
